Skip to main content
. 2020 Sep 19;12(4):147–155. doi: 10.4103/ijt.ijt_19_20

Table 2.

Detailed adverse effects in the posttreatment assessment related to oral minoxidil

First author Posttreatment adverse effects
Beach[26] Hypertrichosis (38.8%), fluid retention (5.5%), hypotensive symptoms (5.5%)
Fiedler-Weiss[32] Hypertrichosis (17.0%), fluid retention, occasional episodes of headaches, depression, or lethargy in women; occasional episodes of palpitations or tachycardia after ingestion of caffeine, alcohol, or decongestants*
Jimenez-Caube[27] Hypertrichosis (24.3%), lower-limb edema (4.8%), hair shredding (2.4%)
Lueangarun[28] Hypertrichosis (93%), pedal edema (10%), ECG abnormality, including premature ventricular contractions and T-wave change (10% of patients)
Ramos[29] Hypertrichosis (27.0%), edema of the limbs (4.0%)
Perera[34] Hypertrichosis (38.8%), transient postural dizziness (5.5%), lower-limb edema (2.7%)
Sinclair[31] Hypertrichosis (4%), urticaria (2%), hypotensive symptoms (2%)
Tanaka[30] Swelling (0.22%), dizziness (0.15%)
Wambier[33] Hypertrichosis (50.0%), acne (25.0%)

*Study did not show quantitative data regarding most of adverse effect described, †Side effect resolved after continued treatment